These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20847138)

  • 1. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
    Gao H; Deng S; Obach RS
    Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments (metabolites in safety testing). II. Application to unstable metabolites.
    Gao H; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1290-6. PubMed ID: 22456937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap.
    Gao H; Materne OL; Howe DL; Brummel CL
    Rapid Commun Mass Spectrom; 2007; 21(22):3683-93. PubMed ID: 17937450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of MK-0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry.
    Shen Z; Kochansky C; Bakhtiar R; Franklin RB; Vincent SH
    Rapid Commun Mass Spectrom; 2004; 18(18):2113-20. PubMed ID: 15317046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
    Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of exposure multiples of human metabolites for MIST assessment in preclinical safety species without using reference standards or radiolabeled compounds.
    Ma S; Li Z; Lee KJ; Chowdhury SK
    Chem Res Toxicol; 2010 Dec; 23(12):1871-3. PubMed ID: 21121646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies.
    Briem S; Martinsson S; Bueters T; Skoglund E
    Rapid Commun Mass Spectrom; 2007; 21(13):1965-72. PubMed ID: 17526069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.
    Yang Y; Grubb MF; Luk CE; Humphreys WG; Josephs JL
    Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3245-51. PubMed ID: 22006386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data-driven approach for cross-species comparative metabolite exposure assessment: how to establish fundamental bioanalytical parameters for the peak area ratio method.
    Gao H; Obach RS
    Bioanalysis; 2014 Mar; 6(5):641-50. PubMed ID: 24620806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.
    Wickremsinhe ER; Ackermann BL; Chaudhary AK
    Rapid Commun Mass Spectrom; 2005; 19(1):47-56. PubMed ID: 15570573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry.
    Fang ZG; You BG; Chen YG; Zhang JK; Liu YQ; Zhang XN; Zhang Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1153-62. PubMed ID: 20381433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of bioanalytical methods for Imidafenacin (KRP-197/ONO-8025) and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
    Masuda Y; Kanayama N; Manita S; Ohmori S; Ooie T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):70-9. PubMed ID: 17387045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'N-in-one' strategy for metabolite identification using a liquid chromatography/hybrid triple quadrupole linear ion trap instrument using multiple dependent product ion scans triggered with full mass scan.
    Li AC; Gohdes MA; Shou WZ
    Rapid Commun Mass Spectrom; 2007; 21(8):1421-30. PubMed ID: 17377936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneously quantifying parent drugs and screening for metabolites in plasma pharmacokinetic samples using selected reaction monitoring information-dependent acquisition on a QTrap instrument.
    Li AC; Alton D; Bryant MS; Shou WZ
    Rapid Commun Mass Spectrom; 2005; 19(14):1943-50. PubMed ID: 15954168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.